UKMRA-MUK-CARP webinar series

Actions and Detail Panel


Event Information

Share this event

Date and time



Online event

Event description
This series aims to provide short talks to introduce the UKMRA-MUK-Concept and Access Research Programme (CARP)

About this event

UKMRA-MUK-Concept and Access Research Programme (CARP) is designed to support researchers in the development of early phase studies which can provide safety or proof of concept data for larger and later phase trials, or data which can be used to support patients gaining access to treatments through the NHS. The series is aimed at researchers wanting to learn about developing their early phase myeloma trial ideas, and how CARP fits within the wider landscape of myeloma research in the UK. It will cover background to the research programme, experiences of researchers developing trials this way, patient experiences and an introduction to phase I trial design. The speakers are senior trialists and patient representatives who are all actively involved in CARP. Each 1 hour session will consist of 30-45 minute talks followed by Q&A for up to 30 minutes.

Webinar 6 -

Thursday 10th February 1.00-2.00pm

Highlights from ASH - an overview of myeloma studies presented

Prof. Gordon Cook will give an overview of key myeloma data presented at the ASH 2021 conference, highlighting in particular those of relevance to the CARP portfolio, and the UKMRA more generally’

Further dates and topics will be confirmed in due course. Watch this space!

Please register your attendance by selecting the relevant date. Webinars will be held via ZOOM and joining details will be sent to those registered via email

Previous webinars in the series

These are now available on our YouTube channel

Webinar 1

Developing early phase myeloma research in the UK: an introduction the UKMRA-MUK-concept and access research programme.

The first webinar is aimed at introducing CARP to researchers. It will give background to developing myeloma trials in the UK and how CARP fits within this. The importance of early phase research from the perspective of Myeloma UK will be discussed. Finally the practicalities of how to develop an early phase clinical trial proposal through CARP will be summarised.

Webinar 2 -

Implementation of an early phase myeloma platform trial

Dr Rakesh Popat will share his experiences of developing and setting up early phase myeloma clinical trials within the CARP. Please join this to hear hands on practical advice from one of our chief investigators on how to transform your idea into a fully funded national clinical trial

Webinar 3 -

Public and Patient Involvement and Engagement

This webinar will focus on public & patient involvement and engagement. Holly Schofield, acting PPIE lead at Leeds CTRU, will talking about what constitutes meaningful public involvement, an overview of the recently updated policy and guidance, and what this means for investigators developing their research projects with the trials unit. Dr Sandra Quinn, Health Services Research Manager at Myeloma UK, will then speak about their Patient and Carer Research Panel and how Myeloma UK supports patient involvement in the development and design of research studies undertaken in the UK and internationally. Finally we will be joined by a patient representative who will share some of their experiences of being involved in research as a public contributor.

Webinar 4 -

Early career experiences of clinical trials research – clinical and academic perspectives

Hear from Drs Charlotte Pawlyn and Christopher Parrish about their experiences of being involved in clinical trials research. They will talk about different routes to becoming members of trial management groups, and leading clinical trials. You will learn about clinical and academic pathways, and the roles both Charlotte and Chris have played in the UKMRA-Myeloma UK CARP research programme, as well as their roles on individual clinical trials.

Webinar 5 -

PI dose finding studies in Multiple Myeloma – A practical overview of design

Hear from statistician Andrew Hall about the practical aspects in designing PI dose finding trials in Multiple Myeloma. Going through the aims and objectives of dose finding studies, the traditional approach and its shortcomings. Introducing model based designs utilised within CARP that improve over the traditional design, including MUK11 and the ProMMise Platform study. The talk will finish with a look ahead as to how modern treatments may require a slightly different approach.

Date and time


Online event

Organiser Leeds CTRU

Organiser of UKMRA-MUK-CARP webinar series

Save This Event

Event Saved